Şahin, ÖmerAkpek, MahmutElçik, DenizKaradavut, SerhatŞimşek, VedatTulmaç, MuratKaya, Mehmet G.2020-06-252020-06-252013closedAccess0003-31971940-1574https://doi.org/10.1177/0003319712440619https://hdl.handle.net/20.500.12587/5553orscelik, ozcan/0000-0003-4349-9852; Orscelik, Ozcan/0000-0003-4349-9852We investigated whether serum bilirubin level (a marker of heme oxygenase activity) is a predictor of high levels of SYNTAX score (SXscore) in patients with acute myocardial infarction. Patients (n = 281; male 77%; mean age 60 +/- 12) who were admitted with ST-elevation myocardial infarctions (STEMIs) were enrolled. Patients were divided into 2 groups. Group 1 was defined as SXscore <22 and group 2 was defined as SXscore >= 22. Total bilirubin levels were significantly higher in the high-SXscore group than in the low-SXscore group (0.86 +/- 0.42 vs 1.02 +/- 0.51, P = .005). A significant correlation was detected between total bilirubin and SXscore (r = .42; P = .001). At multivariate analysis, total bilirubin (odds ratio: 1.86, 95% confidence interval 1.04-3.35; P = .038) was an independent risk factor for high SXscore in patients with STEMI. In conclusion, serum bilirubin level is independently associated with SXscore in patients with STEMI.eninfo:eu-repo/semantics/closedAccessSYNTAX scorebilirubinST-elevated myocardial infarctionBilirubin Levels and the Burden of Coronary Atherosclerosis in Patients With STEMIArticle64320020410.1177/00033197124406192-s2.0-8487600669622492252Q2WOS:000317006400006Q3